Clinical trial Recruiting at 2 sites Interventional Ages 18 to 60

Retraining Neural Pathways to Improve Working Memory After Mild TBI

Official title: Retraining Neural Pathways Improves Cognitive Skills After A Mild Traumatic Brain Injury

Run by Perception Dynamics Institute · NCT03655782 · Data updated 2026-11-12

This study tests PATH+DigitMemory neurotraining to see if it can improve working memory after a mild traumatic brain injury.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment90 (estimated)
SponsorPerception Dynamics Institute
Industry-sponsored
Locations2 sites (San Diego, California and 1 other locations)
StatusRecruiting
StartedOctober 5, 2026
Main results expectedJuly 30, 2029
Study endsSeptember 30, 2029
Registry record updatedOctober 8, 2026
Trial IDNCT03655782 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-60 with a history of mTBI (and some with prior moderate TBI) who have documented visual working memory deficits and meet all inclusion criteria.

Probably not a fit

Patients without visual working memory impairments or those who do not tolerate the training may not experience cognitive benefits.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial will assess whether PATH neurotraining followed by DigitMemory exercises can improve working memory, processing speed, and attention in adults with mild traumatic brain injury. It is a Phase II interventional study enrolling two subgroups of mTBI patients and using a structured 30-minute training protocol delivered over 36 or 54 sessions. Participants will be screened and balanced for factors like age, sex, visual working memory performance, and TBI history, with outcomes focused on cognitive remediation. The trial is designed as minimal-risk and aims to expand understanding of cortical timing-based remediation for concussion-related cognitive disorders. Recruitment will occur through clinician referrals and programmatic partnerships, targeting about 90 participants over three years.

Why it matters

Potential benefit: If successful, participants may experience improved working memory, processing speed, and attention after mTBI.

How similar studies have gone: Prior Phase I work suggested this targeted neurotraining can remediates cognitive deficits after mTBI, and Phase II aims to validate effectiveness in a larger group.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Referred by Clinician verifying that patient has an mTBI (also includes moderate TBI: those who had a severe TBI with a loss of consciousness more than 30 minutes that is now an mTBI) and has a visual working memory loss as determined by first neuropsychological pre-test administered: The Test of Information Processing Skills (TIPS),
2. One or more concussions,
3. Any loss of consciousness from 5- 30 min (not longer than 30 min) to be in mTBI group, otherwise in moderate TBI group.
4. Any loss of memory for events immediately before or after the accident for 24 hours is in mTBI group, otherwise is in moderate TBI group,
5. Any alteration of mental state at the time of the accident (e.g. feeling dazed, disoriented, or confused),
6. Be between the ages of 18 to 60 years, when development and aging are not factors,
7. Agrees to complete the study after hearing the time commitment involved,
8. Has corrected 20/20 visual acuity, and normal motor control so can do PATH neurotraining (signal direction that dim gray stripes move by pushing arrow keys on the computer),
9. Can sign and understand the informed consent form themself,
10. Can drive to test sites or capable of using public transportation (bus or train) to test site.
11. Reads English fluently, so can follow instructions.

Exclusion Criteria:

1. mTBI occurred less than 3 months earlier \[While post-concussive symptoms (PCS) resolve within days post injury in the majority of individuals with mTBI,127 symptoms can endure 3 months post injury or longer, indicating spontaneous recovery and chronic sequela.128 In the general public, between 8% to 33% of mTBI patients have persistent PCS and long-term cognitive and/or behavioral impairments129 that negatively impact quality of life. In the proposed study, we will try to minimize the confound from the spontaneous recovery by only recruiting chronic mTBI subjects, and not recruiting mTBI subjects with mTBI less than 3 months.\] with no maximum time if still experiencing memory problems which will be measured by the TIPS visual working memory (VWM) scores.
2. diagnosis of epilepsy or seizure disorder in last 12 months,
3. diagnosis of moderate depressive disorder or moderate anxiety, having driving limitations in traffic
4. answers 'Yes' to any of the questions on the Columbia Suicide Severity Rating Scale,
5. had a stroke or metabolic derangements causing cognitive impairments, i.e. alcohol or substance abuse,

   And for those chosen to undergo MEG exams:
6. has extensive metal dental hardware (e.g., braces and large metal dentures; fillings are acceptable) or other metal objects in head, neck, or face areas that cause artifacts in MEG data, and are not removable during pre-processing, and
7. has claustrophobia since MRI scanner is in small enclosed space,
8. has a cardiac pacemaker, or 9) is pregnant.

Where it's running

  • University of California at San Diego
    San Diego, California, United States
    Recruiting
  • Perception Dynamics Institute
    Solana Beach, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.